Nicholas Investment Partners’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-62,841
Closed -$5.27M 223
2025
Q1
$5.27M Buy
62,841
+11,244
+22% +$1.05M 0.54% 71
2024
Q4
$4.75M Buy
51,597
+2,116
+4% +$203K 0.42% 87
2024
Q3
$4.6M Buy
49,481
+2,080
+4% +$180K 0.42% 87
2024
Q2
$3.9M Buy
+47,401
New +$3.48M 0.4% 93

Other funds holding LMAT

Nicholas Investment Partners's LMAT Position: Q2 2025 in Review

Nicholas Investment Partners sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 62,841 shares — an estimated $5.27M sold.

Nicholas Investment Partners first reported a position in LMAT in Q2 2024 and held it in 4 quarters. The position peaked at $5.27M in Q1 2025. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

  • Nicholas Investment Partners reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
  • Nicholas Investment Partners sold 62,841 LeMaitre Vascular shares in Q2 2025, an estimated $5.27M.
  • Nicholas Investment Partners first reported a position in LeMaitre Vascular in Q2 2024 and held it in 4 quarters.
  • Nicholas Investment Partners's LeMaitre Vascular position peaked at $5.27M in Q1 2025.
  • 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Nicholas Investment Partners's 13F filing for Q2 2025, filed 14 Aug 2025.